The role of immune checkpoint receptors programmed death 1 (PD-1), cytotoxic T lymphocyte antigen (CTLA-4), and T cell immunoglobulin mucin-3 (TIM-3) in GBM are of particular interest due to their expression patterns in GBM and the recent development of inhibitory therapeutics targeting PD-1 and CTLA-4. Here, HAVCR2 is linked to glioblastoma.